What to look for – and how to avoid common pitfalls in greenfield and brownfield facilities
Whether you are building a new biopharma facility from the ground up or upgrading an existing one, the choice of engineering partner is one of the most consequential decisions you will make. Pharma and biotech projects operate under extreme pressures – compressed timelines, stringent regulatory requirements, evolving technologies, and high capital investment.
In both greenfield and brownfield environments, complexity multiplies – interfaces between process, automation, utilities, validation, and operations must align seamlessly. When the engineering partner is not fully integrated or aligned with your long-term goals, projects can quickly drift into delays, cost overruns, or compliance risks.
So what should companies really look for in an engineering partner? And just as importantly, what are the common pitfalls that undermine these collaborations, and how can they be avoided?
What to Look for in an Engineering Partner
Selecting an engineering partner is about choosing an organisation with the technical capability to translate your scientific and business vision into a compliant, operable, and future-ready facility. The strongest partnerships are built on lifecycle thinking, cross-disciplinary integration, and shared accountability for outcomes.
Key qualities to prioritise include –
- Accelerated time to market – Proven ability to compress project timelines without compromising quality
- Customised solutions – Designs aligned to your specific molecule, modality, and regulatory pathway
- First-time-right execution – Integrated engineering and validation to avoid rework
- Innovation mindset – Adoption of advanced technologies and future-ready approaches
- Management of complexity – Capability to coordinate multiple interfaces across disciplines
- Sustainability built-in – Energy and decarbonisation considerations embedded from the design stage
Common Pitfalls in Engineering Partnerships
Many pharma and biotech companies enter projects with capable vendors, yet encounter setbacks. These failures rarely stem from lack of expertise alone. More often, they arise from structural gaps in collaboration, ownership, or integration.
Understanding these pitfalls early can prevent costly course corrections later.
Frequent challenges include –
- Fragmented responsibilities across multiple vendors
- Misalignment between process design and facility engineering
- Late-stage compliance or validation issues
- Poor integration in brownfield upgrades
- Limited lifecycle support beyond commissioning
How to Overcome These Pitfalls
Avoiding these risks requires more than tighter contracts or governance structures. It requires an engineering partner who assumes end-to-end ownership and aligns with your facility’s entire lifecycle – from concept to completion.
When engineering, automation, validation, and sustainability are delivered within a unified framework, complexity becomes manageable, and decisions become faster and more coherent.
Effective strategies include –
- Engaging a single integrated EPCMV partner
- Aligning process, facility, and automation early
- Embedding compliance and validation from the design stage
- Using simulation and digital tools to reduce risk
- Planning lifecycle support from the outset
Why Integration Matters
Greenfield facilities demand speed, readiness for scale-up, and regulatory certainty. Brownfield upgrades demand precision, minimal disruption, and seamless integration with existing operations.
In both cases, success depends on how well interfaces are managed among new and existing systems, across disciplines, and across project phases. An engineering partner who can navigate these interfaces holistically reduces risk and accelerates outcomes.
Case in Point: Integrated Engineering Delivery in 24 Months
A global pharmaceutical company required a new GMP-compliant production facility with rapid delivery, strict regulatory alignment, automation and seamless integration of process.
ZETA delivered the facility as a fully integrated engineering programme completed in 24 months. Early alignment of process, facility, automation, and compliance minimised interface risks and avoided late redesign, enabling accelerated execution without compromising GMP readiness.
The result was a facility delivered to international regulatory standards, ready for validation and scale-up, with minimal coordination burden on the client.
What Clients Value in the ZETA Partnership
ZETA’s partnership model is built around six core advantages that directly address the realities of biopharma projects.
Clients benefit from accelerated time to market through structured, high-speed execution, significantly shortening delivery timelines. At the same time, every facility is tailored to the client’s exact process and regulatory requirements, ensuring true customisation rather than template-based design.
ZETA’s integrated approach enables first-time-right execution – aligning design, build, and validation from the outset so systems are engineered for compliance and operability on day one. This is reinforced by a strong culture of innovation that keeps facilities future-ready and adaptable to evolving technologies and modalities.
Equally important is ZETA’s ability to manage complexity across both greenfield and brownfield environments, coordinating all interfaces within a single accountable framework. Sustainability is also engineered into the facility architecture, transforming energy efficiency and decarbonisation from compliance obligations into operational advantage.
Together, these capabilities define what clients experience as true partnership: faster delivery, lower lifecycle risk, and facilities ready for science, scale, and the future.
